Search the web
Welcome, Guest
[Sign Out, My Account]
Morningstar_Inc.

Friday, May 27 2016 4:21pm ET - U.S. Markets Closed.
Industry Center - Medical Laboratories & Research
Industry Center > Medical Laboratories & Research
More On This Industry
Summary
·News
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Health Care Plans
· Home Health Care
· Long-Term Care Facilities
· Medical Appliances & Equipment
· Medical Instruments & Supplies
· Medical Practitioners
Top Industries
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Diversified Utilities
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
·Tobacco Products, Other
Complete Industry List...
Morningstar Inc.
In-depth Company Dossier Reports on over 7,500 publicly traded U.S. companies. Click here for your free report.
  
Industry Market Summary
Medical Laboratories & Research
Composite Value: 894.6
Today's Change: -1.03%
S&P 500: -0.02%
chart for
[Medical Laboratories & Research (^YHOh795)]
Medical Laboratories & Research News
Independent Data Safety Monitoring Board Recommends Continuation of CytoSorbents REFRESH I Trial
21 minutes ago (PR Newswire)
MONMOUTH JUNCTION, N.J., May 27, 2016 /PRNewswire/ -- CytoSorbents Corporation (CTSO), a critical care immunotherapy leader commercializing its flagship CytoSorb® blood purification cartridge to prevent or treat deadly inflammation and organ failure in critically-ill and cardiac surgery patients around the world, announced that the independent Data Safety Monitoring Board (DSMB) of the current U.S. REFRESH I cardiac surgery trial positively evaluated the safety data from the first 24 patients in a scheduled meeting, found no safety concerns, and recommended continuation of the trial to completion without changes. REFRESH (REduction in FREe Hemoglobin) I is a company-sponsored 40-patient, multi-center, randomized, controlled safety and feasibility study using CytoSorb® intra-operatively during elective, non-emergent complex cardiac surgery where cardiopulmonary bypass is expected to last longer than 3 hours.
DEADLINE APPROACHING: Khang & Khang LLP Announces The Filing Of A Securities Class Action Lawsuit Against Alere Inc. And Encourages Investors With Losses To Contact The Firm - ()
NOVADAQ to Participate in June Investor Conferences - (GlobeNewswire)
More News on Medical Laboratories & Research: Latest News,
Industry Top Performers
Intraday Price Performance% ChangeMarket Cap
More Top Intraday Price Performers...
Market Capitalization% ChangeMarket Cap
QIAGEN NV QIAGEN ORD SHS [0H1Z.L] -4.28% $451.2 B
Dr. Lal Path Labs Ltd. [LALPATHLAB.NS] -3.94% $79.6 B
Thermo Fisher Scientific Inc Co [TMO] +0.03% $59.5 B
THERMFISCHERDRN [TMOS34.SA] 0.00% $50.7 B
EXOVA GROUP [EXO.L] +0.43% $42.0 B
More Top Companies by Market Cap...
More Top Performers: by Valuation, by Growth, by Financial Strength
Industry Calendar
Upcoming Events
Date Co Event
06/01/16 ALOG Analogic Corp Q3 2016 Earnings Release
07/15/16 SOBI.ST Swedish Orphan Biovitrum publ AB Q2 2016 Earnings Release
07/21/16 DGX Quest Diagnostics Inc Q2 2016 Earnings Release
More Upcoming Events...
Recent Events
Date Co Event
05/24/16 CTSO CYTOSORBENTS COR coverage initiated by Maxim Group
05/19/16 ROSG Rosetta Genomics Ltd. downside earnings surprise (-12.50%)
05/17/16 NSPH Nanosphere, Inc. downgraded by Rodman & Renshaw
More Recent Events...
  
Locate Industry by Company
Enter Symbol:
Industry Statistics
Market Capitalization:669B
Price / Earnings:35.4
Price / Book:-9.2
Net Profit Margin (mrq):6.7%
Price To Free Cash Flow (mrq):-125.7
Return on Equity:8.6%
Total Debt / Equity:46.1
Dividend Yield:0.7%
View Industry Browser
Community Spotlight
Most Active Boards
Board Popularity
ERES
ASTM
OSIP
Unusually Active Boards
Board Variance
ERES
ACCL
AIQ

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Medical Laboratories & Research Headlines
More Finance RSS Feeds


Copyright © 2016 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2016 Morningstar, Inc. All Rights Reserved. Company information © 2016 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?